Xilio Therapeutics | 4:持股变动声明-高管 Russo Rene
Xilio Therapeutics | 4:持股变动声明-高管 Frankenfield Christopher James
Xilio Therapeutics | 4:持股变动声明-高管 Brennan Kevin M.
Xilio Therapeutics | 4:持股变动声明-高管 Luptakova Katarina
Xilio Therapeutics | SC 13G:超过5%持股股东披露文件-Gilead Sciences, Inc.(19.9%)
Xilio Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Rock Springs Capital Management LP(8.71%),Rock Springs Capital LLC(8.71%)等
Xilio Therapeutics | 4:持股变动声明-股东 GILEAD SCIENCES, INC.
Xilio Therapeutics | 3:首次持股声明-股东 GILEAD SCIENCES, INC.
Xilio Therapeutics | SC 13G:超过5%持股股东披露文件-Rock Springs Capital Management LP(5.23%),Rock Springs Capital LLC(5.23%)
Xilio Therapeutics | 4:持股变动声明-股东 Atlas Venture Fund XI, L.P.
Xilio Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-OCTAGON CAPITAL ADVISORS LP(0%),OCTAGON INVESTMENTS MASTER FUND LP(0%)等
Xilio Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-OCTAGON CAPITAL ADVISORS LP(6.48%),OCTAGON INVESTMENTS MASTER FUND LP(6.48%)等
Xilio Therapeutics | 4:持股变动声明-股东 Atlas Venture Fund XI, L.P.
Xilio Therapeutics | 4:持股变动声明-高管 Frankenfield Christopher James
Xilio Therapeutics | 4:持股变动声明-高管 Luptakova Katarina
Xilio Therapeutics | 4:持股变动声明-高管 Brennan Kevin M.
Xilio Therapeutics | 4:持股变动声明-高管 Russo Rene
Xilio Therapeutics | 4:持股变动声明-高管 Luptakova Katarina
Xilio Therapeutics | 3:首次持股声明-高管 Luptakova Katarina
Xilio Therapeutics | 4:持股变动声明-首席执行官 Russo Rene
暂无数据